This text is a result of machine translation.
More than 2600 A-share companies intend to pay a cash dividend of 1.48 trillion yuan, and the banking industry contributes more than 30%
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Nearly 30% of new shares broke on the first day of the year, with CITIC Securities taking the lead in the number of lead underwriters
Diverse BRI Markets Demand Adaptive Strategies from China’s NEV Industry
Updated 26 mins ago
China Deepens Trade with BRI Partners as NEV Companies Go Global
Updated 42 mins ago
DeepSeek | China's AI Global Breakthrough and Ecosystem Restructuring
Mar 19, 2025 01:18 PM